Last update 01 Nov 2024

Opioid receptors x EP2

Basic Info

Related Targets
Opioid receptorsEP2

Related

1
Drugs associated with Opioid receptors x EP2
Taprenepag isopropyl
Target
EP2 x Opioid receptors
Mechanism
EP2 agonists [+1]
Active Org.-
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication-
Inactive Indication
Glaucoma, Open-Angle
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
4
Clinical Trials associated with Opioid receptors x EP2
ACTRN12612000880842 / CompletedPhase 1
A Phase 1, Single-Center, Dose-Ranging, Multi-Treatment Study to Determine the Safety and Pharmacokinetics of Single Oral Dose Combinations of PF329 and Nafamostat Mesilate in Healthy Subjects
ACTRN12610000721000 / CompletedPhase 1
A Phase 1, Single-Center, Dose-Escalation and Fixed-Dose Crossover, Cohort Study to Determine the Safety and Pharmacokinetics of a Single Oral Dose of PF329 versus oral hydromorphone hydrochloride (HCl) in Healthy Subjects
100 Clinical Results associated with Opioid receptors x EP2
Login to view more data
100 Translational Medicine associated with Opioid receptors x EP2
Login to view more data
0 Patents (Medical) associated with Opioid receptors x EP2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free